Institut Gustave Roussy

Gustave Roussy is the first leader cancer-research hospital in Europe and ranked among the top 3 best specialized hospitals in the world . It is a centre for high quality patient care, research and teaching. It is highly-known for the treatment of (among others): skin cancers like melanoma, breast cancer, and lung cancer. It provides access to care with many expert doctors who have historically revolutionized the treatment of cancer and contributed to the surge of new molecules in the treatment of cancers and tumors. It is located in the Parisian area. It is named after Gustave Roussy, a Swiss-French neuropathologist. In April 2019, three new interventional radiology rooms were inaugurated, making it the largest platform of this type in Europe, entirely dedicated to oncology. Interventional radiology is a so-called "minimally invasive" diagnostic and treatment technique, which uses images to guide access to deep-lying organs, without having to "open up" patients. Gustave Roussy carries out more than 4,000 operations of this type each year. Notable people Gustave Roussy, first director (1921–1947) Tabaré Vázquez Maurice Tubiana, fifth director (1982–1988) and member of the French Academy of Sciences Georges Mathé, oncologist and immunologist who performed in 1959 the first successful bone marrow transplant not performed on identical twins. Frédéric Triebel, discoverer of the immune checkpoint molecule LAG3, worked at the institute from 1986 until around 2001 Barbara Tudek (1952-2019), biologist and professor who served as president of the Polish section of the European Environmental Mutagenesis and Genomics Society Gustave-Roussy School of Cancer Sciences Together with the Faculty of Medicine of the University of Paris-Saclay, the Gustave-Roussy Institute runs the School of Cancer Sciences, a university establishment specializing in oncology. The lessons take place at the Cancer Campus in Villejuif in the Val-de-Marne.